Feb 27 |
Theravance Biopharma, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 26 |
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
|
Feb 26 |
Theravance Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $17.6M beats by $0.03M
|
Feb 26 |
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Feb 26 |
Earnings Scheduled For February 26, 2024
|
Feb 25 |
Theravance Biopharma Q4 2023 Earnings Preview
|
Feb 15 |
Will Theravance Biopharma (NASDAQ:TBPH) Spend Its Cash Wisely?
|
Feb 14 |
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
|
Jan 23 |
Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
|
Jan 19 |
Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long
|